Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 160568, 7 pages
http://dx.doi.org/10.1155/2015/160568
Research Article

CO2 Pneumoperitoneum Preserves β-Arrestin 2 Content and Reduces High Mobility Group Box-1 (HMGB-1) Expression in an Animal Model of Peritonitis

1Department of Pediatric, Gynecological, Microbiological and Biomedical Sciences, University of Messina, Azienda Ospedaliera Universitaria Policlinico “G. Martino”, Via Consolare Valeria 1, 98125 Messina, Italy
2Department of Clinical and Experimental Medicine, University of Messina, Azienda Ospedaliera Universitaria Policlinico “G. Martino”, Via Consolare Valeria 1, 98125 Messina, Italy
3Department of Public Health, University of Messina, Azienda Ospedaliera Universitaria Policlinico “G. Martino”, Via Consolare Valeria 1, 98125 Messina, Italy

Received 10 October 2014; Revised 11 January 2015; Accepted 26 January 2015

Academic Editor: Angel Catalá

Copyright © 2015 Angela Simona Montalto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. J. Hanly, J. M. Fuentes, A. R. Aurora et al., “Carbon dioxide pneumoperitoneum prevents mortality from sepsis,” Surgical Endoscopy and Other Interventional Techniques, vol. 20, no. 9, pp. 1482–1487, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Metzelder, J. F. Kuebler, A. Shimotakahara, D.-H. Chang, C. Vieten, and B. Ure, “CO2 pneumoperitoneum increases survival in mice with polymicrobial peritonitis,” European Journal of Pediatric Surgery, vol. 18, no. 3, pp. 171–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Chatzimavroudis, T. E. Pavlidis, I. Koutelidakis et al., “CO2 pneumoperitoneum prolongs survival in an animal model of peritonitis compared to laparotomy,” Journal of Surgical Research, vol. 152, no. 1, pp. 69–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. S. Montalto, A. Bitto, N. Irrera et al., “CO2 pneumoperitoneum impact on early liver and lung cytokine expression in a rat model of abdominal sepsis,” Surgical Endoscopy and Other Interventional Techniques, vol. 26, no. 4, pp. 984–989, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Balagué, E. M. Targarona, M. Pujol, X. Filella, J. J. Espert, and M. Trias, “Peritoneal response to a septic challenge: comparison between open laparotomy, pneumoperitoneum laparoscopy, and wall lift laparoscopy,” Surgical Endoscopy, vol. 13, no. 8, pp. 792–796, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. M. B. Pitombo, O. H. Lupi, R. N. Gomes et al., “Inflammatory response and bacterial dissemination after laparotomy and abdominal CO2 insufflation in a murine model of peritonitis,” Surgical Endoscopy and Other Interventional Techniques, vol. 20, no. 9, pp. 1440–1447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Fan, L. M. Luttrell, G. E. Tempel, J. J. Senn, P. V. Halushka, and J. A. Cook, “β-Arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression,” Molecular Immunology, vol. 44, no. 12, pp. 3092–3099, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Fan, A. Bitto, B. Zingarelli et al., “Beta-arrestin 2 negatively regulates sepsis-induced inflammation,” Immunology, vol. 130, no. 3, pp. 344–351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Bitto, L. Minutoli, A. David et al., “Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis,” Critical Care, vol. 16, no. 1, article R32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Huang, Y. Tang, and L. Li, “HMGB1, a potent proinflammatory cytokine in sepsis,” Cytokine, vol. 51, no. 2, pp. 119–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Wang, O. Bloom, M. Zhang et al., “HMG-1 as a late mediator of endotoxin lethality in mice,” Science, vol. 285, no. 5425, pp. 248–251, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. C. H. Lang, C. Silvis, N. Deshpande, G. Nystrom, and R. A. Frost, “Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle,” Shock, vol. 19, no. 6, pp. 538–546, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Scaffidi, T. Misteli, and M. E. Bianchi, “Release of chromatin protein HMGB1 by necrotic cells triggers inflammation,” Nature, vol. 418, pp. 191–195, 2002. View at Publisher · View at Google Scholar
  14. J. S. Park, F. Gamboni-Robertson, Q. He et al., “High mobility group box 1 protein interacts with multiple Toll-like receptors,” The American Journal of Physiology—Cell Physiology, vol. 290, no. 3, pp. C917–C924, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Wang, M. F. Ward, and A. E. Sama, “Novel HMGB1-inhibiting therapeutic agents for experimental sepsis,” Shock, vol. 32, no. 4, pp. 348–357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Sauerland, F. Agresta, R. Bergamaschi et al., “Laparoscopy for abdominal emergencies: evidence-based guidelines of the European Association for Endoscopic Surgery,” Surgical Endoscopy and Other Interventional Techniques, vol. 20, no. 1, pp. 14–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Hotchkiss and I. E. Karl, “The pathophysiology and treatment of sepsis,” The New England Journal of Medicine, vol. 348, no. 2, pp. 138–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. R. C. Bone, “Why sepsis trials fail,” The Journal of the American Medical Association, vol. 276, no. 7, pp. 565–566, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. L. M. Luttrell and R. J. Lefkowitz, “The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals,” Journal of Cell Science, vol. 115, no. 3, pp. 455–465, 2002. View at Google Scholar · View at Scopus
  22. R. J. Lefkowitz and S. K. Shenoy, “Transduction of receptor signals by beta-arrestins,” Science, vol. 308, no. 5721, pp. 512–517, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. C. O. Gill and K. M. DeLacy, “Growth of Escherichia coli and Salmonella typhimurium on high-pH beef packed under vacuum or carbon dioxide,” International Journal of Food Microbiology, vol. 13, no. 1, pp. 21–30, 1991. View at Publisher · View at Google Scholar · View at Scopus
  24. C. D. Hart, G. C. Mead, and A. P. Norris, “Effects of gaseous environment and temperature on the storage behaviour of Listeria monocytogenes on chicken breast meat,” Journal of Applied Bacteriology, vol. 70, no. 1, pp. 40–46, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Lee, L. Arul, R. Lencki, and F. Castaigne, “A review on modified atmosphere packaging and preservation of fresh fruits and vegetables: physiological basis and practical aspects: part II,” Packaging Technology and Science, vol. 9, no. 1, pp. 1–17, 1996. View at Google Scholar
  26. F. Basher, H. Fan, B. Zingarelli et al., “β-Arrestin 2: a negative regulator of inflammatory responses in polymorphonuclear leukocytes,” International Journal of Clinical and Experimental Medicine, vol. 1, no. 1, pp. 32–41, 2008. View at Google Scholar
  27. Y. Wang, Y. Tang, L. Teng, Y. Wu, X. Zhao, and G. Pei, “Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling,” Nature Immunology, vol. 7, no. 2, pp. 139–147, 2006. View at Publisher · View at Google Scholar · View at Scopus